[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"malignant-head-and-neck-neoplasm\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:malignant-head-and-neck-neoplasm":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100644123","peer-support-program-for-improving-quality-of-life-among-head-and-neck-patients-connecting-through-cancer-trial-100644123",false,"NCT07664241","Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial","Connecting Through Cancer: Feasibility of a Peer Support Program for Head and Neck Patients","Inclusion Criteria:\n\n* MENTEE GROUP: Ability to understand and the willingness to sign a written informed consent document\n* MENTEE GROUP: Willingness to have mentor-mentee interactions with the mentor selected by Imerman Angels (documented as part of informed consent)\n* MENTEE GROUP: Age 18 or older at the time of consent (upper age limit 89)\n* MENTEE GROUP: Diagnosed with head \\& neck cancer (all stages) and planning to receive, currently receiving or recently completed (within 12 months) active treatment OR in follow-up and reporting unmet social\u002Fsupport needs\n* MENTEE GROUP: English-speaker\n* MENTEE GROUP: Access to electronic device that can be used for communication\n* MENTEE GROUP: Eastern Cooperative Oncology Group (ECOG) score less than or equal to 2\n* CAREGIVER GROUP: Ability to understand and the willingness to sign a written informed consent document\n* CAREGIVER GROUP: Age 18 or older at the time of consent (upper age limit 89)\n* CAREGIVER GROUP: Caregiver of patient diagnosed with head and neck cancer who is also enrolled in the study\n* CAREGIVER GROUP: English-speaker\n* CAREGIVER GROUP: Access to electronic device that can be used for communication\n\nExclusion Criteria:\n\n* MENTEE GROUP: Mentee must not be regularly engaging in other support programs at the start of the study intervention\n* MENTEE GROUP: Undergoing active professional treatment for cognitive or emotional difficulties or neurological deficits that preclude adherence to the study protocol\n* MENTEE GROUP: Any other social, emotional, or personal situation that will preclude adherence to the study protocol, at the discretion of the investigator\n* CAREGIVER GROUP: Caregivers must not be regularly engaging in other support programs at the start of the study intervention\n* CAREGIVER GROUP: Undergoing active professional treatment for cognitive or emotional difficulties or neurological deficits that preclude adherence to the study protocol\n* CAREGIVER GROUP: Any other social, emotional, or personal situation that will preclude adherence to the study protocol, at the discretion of the investigator",true,"ALL","18 Years","89 Years",{"count":21,"type":22},56,"ESTIMATED","INTERVENTIONAL",[25],"NA","This clinical trial tests whether a peer support program is feasible for head and neck cancer patients. Social support at the time of diagnosis has been shown to improve head and neck cancer quality of life before and after treatment. However, not all patients have a strong social support system. Recent research has shown that peer support programs have the potential to address unmet social support needs among cancer patients. These programs involve cancer survivors (peer mentors) providing emotional and informational support to cancer patients (mentees) earlier in their disease course. Peer support programs may also reduce caregiver burden by providing an additional source of support for the patient. A one-on-one peer support program may be feasible for patients with head and neck and their caregivers.",[28],"Malignant Head and Neck Neoplasm","NOT_YET_RECRUITING","2026-06-18",{"date":32,"type":33},"2026-06-24","ACTUAL",{"date":35,"type":22},"2026-07-01",{"date":37,"type":22},"2027-12-31",{"name":39,"class":40},"OHSU Knight Cancer Institute","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":23,"phases":51,"briefSummary":52,"conditions":53,"keywords":65,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":74,"locationsCount":41},"100640818","studying-the-workflow-of-the-american-college-of-surgeons-geriatric-surgery-program-to-improve-clinical-outcomes-in-older-adults-undergoing-surgery-at-the-james-cancer-hospital-100640818","NCT07606287","Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital","Implementation of the American College of Surgeons Geriatric Surgery Verification Program at the James Cancer Hospital","Inclusion Criteria:\n\n1. Patient records for adults aged 65 years or older\n2. Patient records with a surgical encounter or preoperative evaluation within participating James Cancer Hospital surgical oncology services during the rollout period\n3. Patient records with data available in institutional electronic health record or institutional data systems\n4. Clinical staff age 18 years or older who are employed or credentialed at The Ohio State University Wexner Medical Center and work within clinical areas affected by ACS Geriatric Surgery Verification implementation\n\nExclusion Criteria:\n\n1. Patient records for encounters occurring only at outside institutions or non-James hospitals within the enterprise\n2. Patient records missing all primary outcome fields after data quality checks\n3. Clinical staff who are trainees, including medical students, physician assistant students, nursing students, resident physicians, or fellows\n4. Clinical staff whose employment, visa, or institutional status would make participation sensitive under institutional policy, if applicable",{"count":50,"type":22},4000,[25],"This study examines how the American College of Surgeons Geriatric Surgery Verification Program, also called the ACS GSV Program, is implemented at the James Cancer Hospital. The program is designed to improve surgical care for adults age 65 and older by helping care teams identify and address age-related needs before, during, and after surgery.\n\nOlder adults with cancer may have concerns related to physical function, memory or thinking, medications, social support, and goals of care. If these needs are not recognized, patients may be at higher risk for complications, longer hospital stays, readmission, or discharge to a facility instead of home.\n\nThe ACS GSV Program includes standards for geriatric surgery leadership, goals-of-care discussions, screening for age-related vulnerabilities, care plans for identified needs, age-friendly perioperative care, and regular review of surgical outcomes. This study will evaluate how well these standards are adopted across surgical oncology services and whether implementation is associated with better outcomes, such as shorter hospital stays, fewer complications, fewer readmissions, and improved discharge outcomes.\n\nThe results may help improve surgical care workflows for older adults undergoing cancer surgery.",[54,55,56,57,28,58,59,60,61,62,63,64],"Breast Carcinoma","Malignant Digestive System Neoplasm","Malignant Female Reproductive System Neoplasm","Malignant Genitourinary System Neoplasm","Malignant Nervous System Neoplasm","Malignant Solid Neoplasm","Malignant Thoracic Neoplasm","Skin Neoplasm","Soft Tissue Neoplasm","Central Nervous System Neoplasm","Endocrine Gland Neoplasms",[66,67],"geriatric surgery verification","oncogeriatrics","2026-05-27",{"date":70,"type":33},"2026-05-29",{"date":72,"type":22},"2026-06-15",{"date":37,"type":22},{"name":75,"class":40},"Ohio State University Comprehensive Cancer Center",{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":23,"phases":85,"briefSummary":86,"conditions":87,"keywords":4,"overallStatus":135,"whyStopped":4,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":41},"100160741","association-between-health-care-provider-hcp-assessed-ecog-performance-status-ps-and-overall-survival-and-objectively-measure-of-physical-activity-pa-levels-in-advance-cancer-patients-100160741","NCT01365169","Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients\"","\"CYCORE: Cyberinfrastructure for Comparative Effectiveness Research - Feasibility Trial\"","Inclusion Criteria:\n\n* Diagnosis of any stage I - IV colorectal cancer or recurrent colorectal cancer (Arm 1)\n* Able to speak, read, and write in English (Pre-pilot phase, Arms 1-4)\n* Able to provide informed consent (Pre-pilot phase, Arms 1-4, PCS study)\n* Lives in the Houston area (Harris county or a contiguous county) (Pre-pilot phase)\n* Eastern Cooperative Oncology Group (ECOG) status of 0 - 2, or self-reports being up and about more than 50% of waking hours and able to provide self-care (Arm 1)\n* Diagnosis of any of the following cancers: stage 1-4b oropharyngeal, hypopharyngeal, nasopharyngeal, salivary gland or oral cavity; stage 3-4b laryngeal; any unknown primary head and neck cancer with cervical metastasis that will be addressed with treatment to bilateral necks and mucosa; or other head and neck cancers medically approved by one of our Radiation Oncology collaborating medical doctors (MDs) (Arms 2 and 3)\n* History of any cancer, other than non-melanoma skin cancer (Arm 4)\n* Admitted to being a current smoker or recent quitter upon admission to MD Anderson Cancer Center (MDACC) (Arm 4)\n* Has a valid home address and functioning home telephone number (Arm 4)\n* Lives in the Houston or surrounding area, or resides in this same area during the time period that coincides with this study (Arms 1-4)\n* Patients who will undergo curative pancreatectomy for pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, or pancreatic cysts (malignant or benign) (PCS study)\n* Fluent in English (PCS study)\n* Must have telephone access and agree to engage with research personnel using telephone (PCS study)\n* Diagnosis of a metastatic or locally unresectable solid tumor (TAPS study)\n* Fluent in English (TAPS study)\n* Age 18 years or older (TAPS study)\n* ECOG performance status score between 0-3 (TAPS study)\n\nExclusion Criteria:\n\n* Major surgery in the past 8 weeks (Arms 1 and 4)\n* Self-reports hypertension that is not being monitored by a physician and is not being managed with either medication, observation, or lifestyle change (Pre-pilot phase, Arms 1-3)\n* Overt cognitive difficulty demonstrated by not being clearly oriented to time or person or place (Arms 1-4)\n* Orthopedic, neurologic, or musculoskeletal disability that would interfere with the functional task of standing on a weight scale (Pre-pilot phase, Arm 2)\n* Not currently receiving radiation treatment for a cancer listed in the arm-specific inclusion criteria (Arms 2 and 3)\n* Zubrod performance status \\> 2, or self-reports either not being up and about more than 50% of waking hours or unable to provide self-care (Arms 2 and 3)\n* Currently receiving treatment for a cancer other than those listed in the arm-specific inclusion criteria (exception: the study does not exclude those receiving treatment for non-melanoma skin cancer) (Arms 2 and 3)\n* History of current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g. dysphagia due to underlying neurogenic disorder) (Arm 3 only)\n* Active substance use disorder (diagnosed or strongly suspected) (Arm 4)\n* Currently enrolled in protocol 2014-0712 (PCS study)\n* No home access to internet (PCS study)\n* No home WiFi connection (PCS study)\n* During clinician's pre-surgical evaluation, presents with high risk for non-therapeutic resection related to cancer diagnosis (PCS study)\n* Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV) (PCS study)\n* Recent fracture or acute musculoskeletal injury that precludes the ability to fully bear weight on all 4 limbs in order to participate in an exercise intervention (PCS study)\n* Poorly-controlled pain with a self-reported pain score of 7\u002F10 at the time of enrollment (PCS study)\n* Myopathic or rheumatologic disease that impacts physical function (PCS study)\n* Has a pacemaker or other internal medical device, or reports being pregnant (PCS study)\n* Currently enrolled in protocol 2017-0198 (PCS study)\n* Demonstration of overt cognitive difficulty as demonstrated by not being clearly oriented to time or person or place (TAPS study)",{"count":84,"type":22},590,[25],"The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with health care provider (HCP)-assessed ECOG performance status and overall survival. The purpose is to advance the evidence-base for incorporating objective assessment of Physical Activity (PA) in the context of performance status assessment in advanced cancer patients.",[28,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134],"Malignant Neoplasm","Metastatic Malignant Neoplasm in the Neck","Metastatic Malignant Neoplasm in the Uterine Cervix","Pancreatic Adenocarcinoma","Pancreatic Neuroendocrine Carcinoma","Recurrent Colorectal Carcinoma","Stage I Colorectal Cancer AJCC v6 and v7","Stage I Hypopharyngeal Carcinoma AJCC v7","Stage I Major Salivary Gland Cancer AJCC v7","Stage I Nasopharyngeal Carcinoma AJCC v7","Stage I Oral Cavity Cancer AJCC v6 and v7","Stage I Oropharyngeal Carcinoma AJCC v6 and v7","Stage II Colorectal Cancer AJCC v7","Stage II Hypopharyngeal Carcinoma AJCC v6 and v7","Stage II Major Salivary Gland Cancer AJCC v7","Stage II Nasopharyngeal Carcinoma AJCC v7","Stage II Oral Cavity Cancer AJCC v6 and v7","Stage II Oropharyngeal Carcinoma AJCC v6 and v7","Stage IIA Colorectal Cancer AJCC v7","Stage IIB Colorectal Cancer AJCC v7","Stage IIC Colorectal Cancer AJCC v7","Stage III Colorectal Cancer AJCC v7","Stage III Hypopharyngeal Carcinoma AJCC v7","Stage III Laryngeal Cancer AJCC v6 and v7","Stage III Major Salivary Gland Cancer AJCC v7","Stage III Nasopharyngeal Carcinoma AJCC v7","Stage III Oral Cavity Cancer AJCC v6 and v7","Stage III Oropharyngeal Carcinoma AJCC v7","Stage IIIA Colorectal Cancer AJCC v7","Stage IIIB Colorectal Cancer AJCC v7","Stage IIIC Colorectal Cancer AJCC v7","Stage IV Colorectal Cancer AJCC v7","Stage IVA Colorectal Cancer AJCC v7","Stage IVA Hypopharyngeal Carcinoma AJCC v7","Stage IVA Laryngeal Cancer AJCC v7","Stage IVA Major Salivary Gland Cancer AJCC v7","Stage IVA Nasopharyngeal Carcinoma AJCC v7","Stage IVA Oral Cavity Cancer AJCC v6 and v7","Stage IVA Oropharyngeal Carcinoma AJCC v7","Stage IVB Colorectal Cancer AJCC v7","Stage IVB Hypopharyngeal Carcinoma AJCC v7","Stage IVB Laryngeal Cancer AJCC v7","Stage IVB Major Salivary Gland Cancer AJCC v7","Stage IVB Nasopharyngeal Carcinoma AJCC v7","Stage IVB Oral Cavity Cancer AJCC v6 and v7","Stage IVB Oropharyngeal Carcinoma AJCC v7","Metastatic or Locally Unresectable Solid Tumor","RECRUITING","2026-01-05",{"date":138,"type":33},"2026-01-07",{"date":140,"type":33},"2011-05-25",{"date":142,"type":22},"2027-06-30",{"name":144,"class":40},"M.D. Anderson Cancer Center"]